Mersana Therapeutics, Inc. Operating Leases, Rent Expense, Net
Mersana Therapeutics, Inc. reported Operating Leases, Rent Expense, Net of $1.99 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseNet · last filed 2020-02-28
- Mersana Therapeutics, Inc. operating leases, rent expense, net for the quarter ending 2018-12-31 was $512.00K, a 11.42% decline year-over-year.
- Mersana Therapeutics, Inc. operating leases, rent expense, net for the quarter ending 2018-09-30 was $504.00K, a 20.29% increase year-over-year.
- Mersana Therapeutics, Inc. operating leases, rent expense, net for the quarter ending 2018-06-30 was $497.00K, a 18.62% increase year-over-year.
- Mersana Therapeutics, Inc. operating leases, rent expense, net for the quarter ending 2018-03-31 was $466.00K, a 4.25% increase year-over-year.
- Mersana Therapeutics, Inc. operating leases, rent expense, net for fiscal 2018 was $1.99M, a 8.72% increase from fiscal 2017.
- Mersana Therapeutics, Inc. operating leases, rent expense, net for fiscal 2017 was $1.83M, a 16.67% increase from fiscal 2016.
- Mersana Therapeutics, Inc. operating leases, rent expense, net for fiscal 2016 was $1.57M, a 66.00% increase from fiscal 2015.
- Mersana Therapeutics, Inc. operating leases, rent expense, net for fiscal 2015 was $947.00K.
| Period end | Operating Leases, Rent Expense, Net 3 month | Operating Leases, Rent Expense, Net 6 month | Operating Leases, Rent Expense, Net 9 month | Operating Leases, Rent Expense, Net 12 month |
|---|---|---|---|---|
| 2018-12-31 | $512.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.02M derived: sum of 2 quarters · filed 2020-02-28 | $1.51M derived: sum of 3 quarters · filed 2020-02-28 | $1.99M 10-K · filed 2020-02-28 |
| 2018-09-30 | $504.00K 10-Q · filed 2018-11-13 | $1.00M derived: sum of 2 quarters · filed 2018-11-13 | $1.48M 10-Q · filed 2018-11-13 | $2.04M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $497.00K 10-Q · filed 2018-08-14 | $978.00K 10-Q · filed 2018-08-14 | $1.54M derived: sum of 3 quarters · filed 2020-02-28 | $1.96M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $466.00K 10-Q · filed 2018-05-15 | $1.04M derived: sum of 2 quarters · filed 2020-02-28 | $1.46M derived: sum of 3 quarters · filed 2020-02-28 | $1.88M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $578.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $997.00K derived: sum of 2 quarters · filed 2020-02-28 | $1.42M derived: sum of 3 quarters · filed 2020-02-28 | $1.83M 10-K · filed 2020-02-28 |
| 2017-09-30 | $419.00K 10-Q · filed 2018-11-13 | $838.00K derived: sum of 2 quarters · filed 2018-11-13 | $1.26M 10-Q · filed 2018-11-13 | $1.60M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $419.00K 10-Q · filed 2018-08-14 | $838.00K 10-Q · filed 2018-08-14 | $1.18M derived: sum of 3 quarters · filed 2019-03-08 | $1.60M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $447.00K 10-Q · filed 2018-05-15 | $763.00K derived: sum of 2 quarters · filed 2019-03-08 | $1.18M derived: sum of 3 quarters · filed 2019-03-08 | $1.60M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $735.00K derived: sum of 2 quarters · filed 2019-03-08 | $1.15M derived: sum of 3 quarters · filed 2019-03-08 | $1.57M 10-K · filed 2019-03-08 |
| 2016-09-30 | $419.00K 10-Q · filed 2017-11-13 | $838.00K derived: sum of 2 quarters · filed 2017-11-13 | $1.26M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $419.00K 10-Q · filed 2017-08-11 | $838.00K 10-Q · filed 2017-08-11 | ||
| 2015-12-31 | $947.00K 10-K · filed 2018-03-28 |